Integra LifeSciences said third-quarter revenue is expected to come in at about $410 million to $412 million, down from the company’s prior full-year pace implied by its earlier outlook and reflecting an estimated $7 million hit from July flooding at its Cincinnati facility.
Adjusted earnings per diluted share for the quarter are expected to be $0.55 to $0.59. For the full year, Integra cut its revenue outlook to $1.634 billion to $1.654 billion from $1.654 billion to $1.695 billion, a reduction of $20 million to $41 million at the top and bottom of the range.
The company also lowered its adjusted EPS forecast for 2026 to $2.30 to $2.40 from $2.40 to $2.50, trimming the range by 10 cents on both ends.
Integra said the Cincinnati flooding is expected to reduce fourth-quarter revenue by another $15 million to $20 million. It now expects the facility to return to full manufacturing operations in the second quarter of 2027.
Despite the revenue and earnings cuts, Integra kept its operating cash flow outlook intact at about $190 million to $200 million for the full year, and said it expects more than $85 million of operating cash flow in the third quarter alone. As a result of these announcements, the company's shares have moved -1.17% on the market, and are now trading at a price of $16.09. For more information, read the company's full 8-K submission here.
